Robert A. Bonomo

Internal Medicine

10701 East Blvd
Cleveland, OH 44106

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 651 publications

In vitro potency of novel ertapenem/zidebactam combination (WCK 6777) against carbapenemase-producing Enterobacterales collected across India.

In vitro potency of novel ertapenem/zidebactam combination (WCK 6777) against carbapenemase-producing Enterobacterales collected across India.

Journal: JAC-antimicrobial resistance

Published: September 07, 2026

Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.

Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 28, 2026

PER-14, a β-lactamase variant with reduced sensitivity to avibactam and relebactam.

PER-14, a β-lactamase variant with reduced sensitivity to avibactam and relebactam.

Journal: Antimicrobial agents and chemotherapy

Published: July 21, 2026

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

Journal: mBio

Published: June 17, 2026

Nutrient-driven small-colony variants as an adaptive outcome in Carbapenem-resistant Acinetobacter baumannii.

Nutrient-driven small-colony variants as an adaptive outcome in Carbapenem-resistant Acinetobacter baumannii.

Journal: Current research in microbial sciences

Published: June 08, 2026

Standardized numbering and alignment of the KPC family of β-lactamases.

Standardized numbering and alignment of the KPC family of β-lactamases.

Journal: Antimicrobial agents and chemotherapy

Published: May 29, 2026

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas study.

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas study.

Journal: Antimicrobial agents and chemotherapy

Published: May 15, 2026

Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.

Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.

Journal: Antimicrobial agents and chemotherapy

Published: April 30, 2026

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

Journal: ACS infectious diseases

Published: April 28, 2026

Double deletion mutation induced active site remodelling modulates substrate specificity in KPC-14 β-lactamase.

Double deletion mutation induced active site remodelling modulates substrate specificity in KPC-14 β-lactamase.

Journal: International journal of biological macromolecules

Published: April 22, 2026

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

Journal: mBio

Published: April 08, 2026

Humanizing meropenem dosage regimens by co-administration of cilastatin in an immunocompetent mouse bloodstream infection model of Acinetobacter baumannii based on a novel quantitative matching framework.

Humanizing meropenem dosage regimens by co-administration of cilastatin in an immunocompetent mouse bloodstream infection model of Acinetobacter baumannii based on a novel quantitative matching framework.

Journal: The Journal of antimicrobial chemotherapy

Published: April 06, 2026

Showing 1-12 of 651

Last Updated: 09/26/2026